QMI — Nucleic Acid Amplification Test For The Quantitation Of Bk Virus (Bk) Dna Class II

FDA Device Classification

Classification Details

Product Code
QMI
Device Class
Class II
Regulation Number
866.3183
Submission Type
Review Panel
MI
Medical Specialty
Microbiology
Implant
No

Definition

An in vitro nucleic acid amplification test for the quantitation of BK virus (BKV) DNA in human samples intended for use as an aid in the management of BKV in transplant patients. In patients undergoing monitoring of BKV, serial DNA measurements can be used to indicate the need for potential treatment changes and to assess viral response to treatment. Test results are intended to be read and analyzed by a qualified licensed healthcare professional in conjunction with clinical signs and symptoms and relevant laboratory findings. Test results must not be the sole basis for patient management decisions.

Recent 510(k) Clearances

K-NumberApplicantDevice NameDate
K241921abbott molecularAlinity m BKVMarch 24, 2025
K202215roche molecular systemscobas BKV, cobas EBV/BKV Control Kit, cobas Buffer Negative Control KitSeptember 2, 2020